January 3, 2012 -- Vivo Ventures, a California healthcare investment firm that invests in both US and China life science companies, closed its seventh fund, Vivo Ventures VII, at $375 million. In the US, the fund will target US companies in the later stage of development. Its China investments will seek enterprises that are producing revenues. More details....
